Financial reports
ARS
2023 FY
Annual report to shareholders
11 Apr 24
10-K
2023 FY
Annual report
27 Feb 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
13 Apr 23
10-K
2022 FY
Annual report
28 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Entry into a Material Definitive Agreement
4 Mar 24
8-K
Results of Operations and Financial Condition
27 Feb 24
8-K
Sotera Health Chairman and CEO Presents at 42nd Annual J.P. Morgan Healthcare Conference
9 Jan 24
8-K
Other Events
21 Dec 23
8-K
Departure of Directors or Certain Officers
13 Nov 23
8-K
Sotera Health Reports Third-Quarter and Year-to-Date 2023 Results
1 Nov 23
8-K
Other Events
16 Oct 23
8-K
Sotera Health Reports Second-Quarter and First-Half 2023 Results
3 Aug 23
8-K
Regulation FD Disclosure
7 Jul 23
8-K
Sotera Health Announces Jon Lyons as New Senior Vice President and Chief Financial Officer
26 Jun 23
Registration and prospectus
424B7
Prospectus with selling stockholder info
29 Feb 24
424B7
Prospectus with selling stockholder info
27 Feb 24
S-3ASR
Automatic shelf registration
27 Feb 24
424B4
Prospectus supplement with pricing info
18 Mar 21
S-1
IPO registration
15 Mar 21
DRS
Draft registration statement
1 Mar 21
S-8
Registration of securities for employees
23 Nov 20
424B4
Prospectus supplement with pricing info
23 Nov 20
8-A12B
Registration of securities on exchange
19 Nov 20
FWP
Free writing prospectus
19 Nov 20
Proxies
DEFA14A
Additional proxy soliciting materials
11 Apr 24
DEF 14A
Definitive proxy
11 Apr 24
PRE 14A
Preliminary proxy
22 Mar 24
DEFA14A
Additional proxy soliciting materials
13 Apr 23
DEF 14A
Definitive proxy
13 Apr 23
DEFA14A
Additional proxy soliciting materials
14 Apr 22
DEF 14A
Definitive proxy
14 Apr 22
DEFA14A
Additional proxy soliciting materials
15 Apr 21
DEF 14A
Definitive proxy
15 Apr 21
Other
SD
Conflict minerals disclosure
31 May 23
EFFECT
Notice of effectiveness
18 Mar 21
CORRESP
Correspondence with SEC
15 Mar 21
CORRESP
Correspondence with SEC
15 Mar 21
UPLOAD
Letter from SEC
5 Mar 21
CERT
Certification of approval for exchange listing
20 Nov 20
EFFECT
Notice of effectiveness
20 Nov 20
SEC STAFF
SEC staff action: Order
20 Nov 20
CORRESP
Correspondence with SEC
17 Nov 20
CORRESP
Correspondence with SEC
17 Nov 20
Ownership
4
Change in insider ownership
6 Mar 24
4
Change in insider ownership
6 Mar 24
4
Change in insider ownership
6 Mar 24
4
Jonathan M. Lyons
6 Mar 24
4
ALEXANDER DIMITRIEF
6 Mar 24
4
Ann R. Klee
6 Mar 24
4
Michael P Rutz
5 Mar 24
4
Michael B. Jr. Petras
5 Mar 24
4
Michael P Rutz
22 Nov 23
4
Michael B. Jr. Petras
22 Nov 23